SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
06-Jul-23 4:14 PM View: | Novocure Ltd (NVCR) | 30-Jun-23 | Grant | 357 | $35.28 | $12,595.00 | < 1% 66.09K to 66.45K | |
07-Mar-23 4:50 PM View: | Novocure Ltd (NVCR) | 03-Mar-23 | Private Sale | 593 | $76.16 | $45,162.50 | (< 1%) 66.68K to 66.09K | |
06-Mar-23 4:42 PM View: | Novocure Ltd (NVCR) | 02-Mar-23 | Private Sale | 281 | $75.28 | $21,153.10 | (< 1%) 66.96K to 66.68K | |
02-Mar-23 4:51 PM View: | Novocure Ltd (NVCR) | 01-Mar-23 | Sale | 755 | $76.36 | $57,653.60 | (1%) 67.72K to 66.96K | |
02-Mar-23 4:51 PM View: | Novocure Ltd (NVCR) | 28-Feb-23 | Grant | 12,125 | -- | -- | 22% 55.59K to 67.72K | |
10-Jan-23 4:13 PM View: | Novocure Ltd (NVCR) | 06-Jan-23 | Grant | 108 | $62.31 | $6,728.94 | < 1% 55.49K to 55.59K | 5% |
06-Sep-22 5:16 PM View: | Novocure Ltd (NVCR) | 02-Sep-22 | Private Sale | 718 | $79.04 | $56,748.60 | (1%) 56.2K to 55.49K | |
07-Jul-22 5:44 PM View: | Novocure Ltd (NVCR) | 05-Jul-22 | Grant | 213 | $59.08 | $12,583.00 | < 1% 55.99K to 56.2K | 11% |
09-Mar-22 4:53 PM View: | Novocure Ltd (NVCR) | 08-Mar-22 | Private Sale | 1,037 | $70.10 | $72,693.70 | (2%) 57.03K to 55.99K | |
07-Mar-22 6:17 PM View: | Novocure Ltd (NVCR) | 04-Mar-22 | Sale | 1,026 | $70.41 | $72,237.60 | (2%) 58.05K to 57.03K | |
07-Mar-22 6:17 PM View: | Novocure Ltd (NVCR) | 03-Mar-22 | Grant | 7,445 | -- | -- | 15% 50.95K to 58.4K | |
07-Mar-22 6:17 PM View: | Novocure Ltd (NVCR) | 03-Mar-22 | Sale | 341 | $74.50 | $25,403.80 | (< 1%) 58.4K to 58.05K | |
12-Jan-22 5:39 PM View: | Novocure Ltd (NVCR) | 06-Jan-22 | Grant | 80 | $63.82 | $5,105.44 | < 1% 50.87K to 50.95K | |
05-Jan-22 4:52 PM View: | Novocure Ltd (NVCR) | 03-Jan-22 | Option Exercise | 28,604 | $10.49 | $299,996.00 | 109% 26.22K to 54.82K | |
05-Jan-22 4:52 PM View: | Novocure Ltd (NVCR) | 03-Jan-22 | Market Option Sale | 919 | $76.09 | $69,924.00 | (2%) 54.82K to 53.9K | |
05-Jan-22 4:52 PM View: | Novocure Ltd (NVCR) | 03-Jan-22 | Market Option Sale (Planned) | 3,032 | $75.97 | $230,339.00 | (6%) 53.9K to 50.87K |